Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NB398403

Novus Biologicals™ CD14 Recombinant Protein Antigen
SDP

Catalog No. NB398403 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398403 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398403 Supplier Novus Biologicals™ Supplier No. NBP234486PEP
Only null left
Add to Cart
Add to Cart

Description

Recombinant Protein

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1M Urea, pH 7.4.
Gene ID (Entrez) 929
Molecular Weight (g/mol) 31 kDa
Quantity 100 μL
Storage Requirements Store at -20°C. Avoid freeze-thaw cycles.
Gene Alias CD14 antigen, CD14 molecule, monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein
Gene Symbol CD14
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-34486. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL.
Research Category Adaptive Immunity, Apoptosis, Asthma, Biologically Active Proteins, Cancer, Cell Biology, Cytokine Research, Immunology, Innate Immunity, Myeloid Cell Markers, Stem Cell Markers
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein CD14
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.